Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-318105

CEO acquired 4,568 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Weis Holger · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-23 Grant or award : show line 1 in the form +4,568 $1.92 $8,771 21,120 D
Loading xslF345X06/ownership.xml…